BIOMAT Database Logo BIOMAT Database Logo

Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole. 1970

R W Brockman, and S Shaddix, and W R Laster, and F M Schabel

UI MeSH Term Description Entries
D007042 Hypoxanthines Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
D007930 Leucine An essential branched-chain amino acid important for hemoglobin formation. L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008297 Male Males
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D002247 Carbon Isotopes Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope. Carbon Isotope,Isotope, Carbon,Isotopes, Carbon
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females

Related Publications

R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
November 1991, Cancer research,
R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
February 1988, Cancer research,
R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N'-aminoguanidine derivatives.
August 1985, Biochemical pharmacology,
R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
Ribonucleotide reductase and mitochondrial DNA synthesis.
June 2007, Nature genetics,
R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
Differential turnover of the subunits of ribonucleotide reductase in synchronized leukemia L1210 cells.
December 1986, Cancer research,
R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
Ribonucleotide reductase activity and growth of glutathione-depleted mouse leukemia L1210 cells in vitro.
June 1988, Cancer letters,
R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
Replication stress induced by the ribonucleotide reductase inhibitor guanazole, triapine and gemcitabine in fission yeast.
March 2022, FEMS yeast research,
R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
Inhibition of ribonucleotide reductase by caracemide.
October 1984, Cancer treatment reports,
R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
Effects of cannabinoids on L1210 murine leukemia. 1. Inhibition of DNA synthesis.
August 1977, Research communications in chemical pathology and pharmacology,
R W Brockman, and S Shaddix, and W R Laster, and F M Schabel
The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).
January 1985, Pharmacology & therapeutics,
Copied contents to your clipboard!